drugmaker
- Business
Novartis stock jumps after drugmaker raises stout-year steering, launches $15 billion buyback
Novartis shares jumped on Tuesday after the Swiss drugmaker raised its stout-year steering on strong drug sales and launched a…
Read More » - HEALTH AND SCIENCE
Drugmaker AstraZeneca adapting COVID-9 vaccine to fight the new variants of the virus
In the face of new variants of the virus, drugmaker AstraZeneca is planning to adapt its Covid-19 vaccine. Well, the…
Read More »